Compare ADUS & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADUS | GRDN |
|---|---|---|
| Founded | 1979 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Retail-Drug Stores and Proprietary Stores |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 2009 | 2024 |
| Metric | ADUS | GRDN |
|---|---|---|
| Price | $114.68 | $29.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 2 |
| Target Price | ★ $138.73 | $32.00 |
| AVG Volume (30 Days) | 189.6K | ★ 351.5K |
| Earning Date | 11-03-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 6.76 | N/A |
| EPS | ★ 4.66 | 0.28 |
| Revenue | $1,346,596,000.00 | ★ $1,389,638,000.00 |
| Revenue This Year | $25.50 | $19.50 |
| Revenue Next Year | $7.11 | $0.48 |
| P/E Ratio | ★ $24.57 | $105.18 |
| Revenue Growth | ★ 18.77 | 18.68 |
| 52 Week Low | $88.96 | $17.78 |
| 52 Week High | $136.72 | $37.43 |
| Indicator | ADUS | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 46.87 | 56.79 |
| Support Level | $119.16 | $28.62 |
| Resistance Level | $121.59 | $29.90 |
| Average True Range (ATR) | 3.18 | 1.04 |
| MACD | 0.51 | -0.06 |
| Stochastic Oscillator | 52.52 | 62.26 |
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, mainly to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are medical in nature to those individuals who may require assistance during an illness or after surgery.
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.